(Q39784883)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Jonathan Harris

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Nathan V Subramaniam

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

3

V Nathan Subramaniam

1 reference

14 September 2017

Daniel F Wallace

1

1 reference

14 September 2017

Jonathan M Harris

series ordinal

2

1 reference

14 September 2017

21 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Cell Physiology

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

C75-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19846751%20AND%20SRC:MED&resulttype=core&format=json

A novel mammalian iron-regulated protein involved in intracellular iron metabolism

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

RETRACTED: The hepcidin-binding site on ferroportin is evolutionarily conserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

The molecular mechanism of hepcidin-mediated ferroportin down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Evidence for the multimeric structure of ferroportin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

The molecular basis of ferroportin-linked hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Wild-type and mutant ferroportins do not form oligomers in transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Functional consequences of ferroportin 1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Impaired iron transport activity of ferroportin 1 in hereditary iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Hepcidin in iron overload disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

21 January 2018

The ferroportin disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Ferroportin is a monomer in vivo in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Ferroportin: lack of evidence for multimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

One-step site-directed mutagenesis of ATM cDNA in large (20kb) plasmid constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Structural conservation in the major facilitator superfamily as revealed by comparative modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

21 January 2018

Non-HFE haemochromatosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008

Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00621.2008